Ameritas Investment Partners’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $37.8K | Hold |
4,560
| – | – | ﹤0.01% | 2268 |
|
|
2025
Q4 | $56.4K | Hold |
4,560
| – | – | ﹤0.01% | 2044 |
|
|
2025
Q3 | $40.2K | Sell |
4,560
-950
| -17% | -$7.39K | ﹤0.01% | 2299 |
|
|
2025
Q2 | $35.2K | Buy |
+5,510
| New | +$31.5K | ﹤0.01% | 2390 |
|
|
2024
Q2 | – | Sell |
-3,841
| Closed | -$9.72K | – | 3160 |
|
|
2024
Q1 | $9.72K | Hold |
3,841
| – | – | ﹤0.01% | 2819 |
|
|
2023
Q4 | $9.22K | Hold |
3,841
| – | – | ﹤0.01% | 2866 |
|
|
2023
Q3 | $13.1K | Hold |
3,841
| – | – | ﹤0.01% | 2719 |
|
|
2023
Q2 | $28.2K | Hold |
3,841
| – | – | ﹤0.01% | 2368 |
|
|
2023
Q1 | $39.8K | Hold |
3,841
| – | – | ﹤0.01% | 2118 |
|
|
2022
Q4 | $52K | Hold |
3,841
| – | – | ﹤0.01% | 2028 |
|
|
2022
Q3 | $80K | Hold |
3,841
| – | – | ﹤0.01% | 1660 |
|
|
2022
Q2 | $119K | Hold |
3,841
| – | – | 0.01% | 1385 |
|
|
2022
Q1 | $158K | Hold |
3,841
| – | – | 0.01% | 1332 |
|
|
2021
Q4 | $167K | Sell |
3,841
-12,450
| -76% | -$563K | 0.01% | 1337 |
|
|
2021
Q3 | $816K | Hold |
16,291
| – | – | 0.03% | 671 |
|
|
2021
Q2 | $1.03M | Buy |
16,291
+170
| +1% | +$10.9K | 0.04% | 613 |
|
|
2021
Q1 | $1.5M | Sell |
16,121
-109
| -0.7% | -$11.2K | 0.06% | 406 |
|
|
2020
Q4 | $1.45M | Sell |
16,230
-382
| -2% | -$35.1K | 0.07% | 380 |
|
|
2020
Q3 | $1.72M | Buy |
16,612
+12,636
| +318% | +$1.36M | 0.08% | 269 |
|
|
2020
Q2 | $314K | Sell |
3,976
-125
| -3% | -$9.31K | 0.02% | 842 |
|
|
2020
Q1 | $237K | Buy |
4,101
+134
| +3% | +$7.72K | 0.01% | 856 |
|
|
2019
Q4 | $214K | Buy |
3,967
+234
| +6% | +$12.7K | 0.01% | 1048 |
|
|
2019
Q3 | $195K | Hold |
3,733
| – | – | 0.01% | 1069 |
|
|
2019
Q2 | $180K | Hold |
3,733
| – | – | 0.01% | 1127 |
|
|
2019
Q1 | $189K | Hold |
3,733
| – | – | 0.01% | 1080 |
|
|
2018
Q4 | $221K | Hold |
3,733
| – | – | 0.01% | 921 |
|
|
2018
Q3 | $246K | Hold |
3,733
| – | – | 0.01% | 973 |
|
|
2018
Q2 | $188K | Buy |
3,733
+845
| +29% | +$44K | 0.01% | 1100 |
|
|
2018
Q1 | $152K | Hold |
2,888
| – | – | 0.01% | 1230 |
|
|
2017
Q4 | $134K | Hold |
2,888
| – | – | 0.01% | 1327 |
|
|
2017
Q3 | $107K | Sell |
2,888
-230
| -7% | -$8.32K | 0.01% | 1418 |
|
|
2017
Q2 | $106K | Buy |
3,118
+587
| +23% | +$18.1K | 0.01% | 1430 |
|
|
2017
Q1 | $74K | Buy |
+2,531
| New | +$77K | ﹤0.01% | 1601 |
|
Other funds holding EBS
VCM
PCM
VPM
Ameritas Investment Partners's EBS Position: Q1 2026 in Review
Ameritas Investment Partners held its Emergent Biosolutions (EBS) position steady in Q1 2026 at 4,560 shares worth $37.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2268.
Ameritas Investment Partners first reported a position in EBS in Q1 2017 and has held it in 33 quarters since. The position peaked at $1.72M in Q3 2020. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.
- Ameritas Investment Partners held 4,560 shares of Emergent Biosolutions worth $37.8K as of Q1 2026.
- Ameritas Investment Partners left its Emergent Biosolutions share count unchanged in Q1 2026.
- Emergent Biosolutions made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2268 holding.
- Ameritas Investment Partners first reported a position in Emergent Biosolutions in Q1 2017 and has held it in 33 quarters since.
- Ameritas Investment Partners's Emergent Biosolutions position peaked at $1.72M in Q3 2020.
- 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.